M. El Dinali

Rare occurrence of EGFRvIII deletion in head and neck squamous cell carcinoma.

Christopher D. Brown, K. White, E. Vokes, 2015, Oral oncology.

Developing a Predictive Model for Clinical Outcomes of Advanced Non‐Small Cell Lung Cancer Patients Treated With Nivolumab

A. Ishkanian, G. Lopes, Y. Chae, 2017, Clinical lung cancer.

mTOR as a Molecular Target in HPV-Associated Oral and Cervical Squamous Carcinomas

S. Hewitt, T. Seiwert, J. S. Gutkind, 2012, Clinical Cancer Research.

RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma

Y. Bang, R. Salgia, E. Vokes, 2011, Cancer biology & therapy.

The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.

J. Christensen, R. Salgia, E. Vokes, 2009, Cancer research.

Oral cavity tumors in younger patients show a poor prognosis and do not contain viral RNA.

Megan E. McNerney, K. White, M. McNerney, 2013, Oral oncology.

MEF2B is a member of the BCL6 gene transcriptional complex and induces its expression in diffuse large B-cell lymphoma of the germinal center B-cell-like type

J. Teruya-Feldstein, A. Firpo-Betancourt, He Zhou, 2018, Laboratory Investigation.